Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Stephanie M. Rasmussen"'
Autor:
Sadiq Umar, Anil K. Singh, Mukesh Chourasia, Stephanie M. Rasmussen, Jeffrey H. Ruth, Salahuddin Ahmed
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
O-GlcNAcylation is a reversible post-translational modification that regulates numerous cellular processes, including embryonic development as well as immune responses. However, its role in inflammation remains ambiguous. This study was designed to e
Externí odkaz:
https://doaj.org/article/f0b7ab4a371e402b91914c7241a45adc
Autor:
Jeffrey H. Ruth, Mikel Gurrea-Rubio, Kalana S. Athukorala, Stephanie M. Rasmussen, Daniel P. Weber, Peggy M. Randon, Rosemary J. Gedert, Matthew E. Lind, M. Asif Amin, Phillip L. Campbell, Pei-Suen Tsou, Yang Mao-Draayer, Qi Wu, Thomas M. Lanigan, Venkateshwar G. Keshamouni, Nora G. Singer, Feng Lin, David A. Fox
Publikováno v:
JCI Insight, Vol 6, Iss 5 (2021)
Limitations of checkpoint inhibitor cancer immunotherapy include induction of autoimmune syndromes and resistance of many cancers. Since CD318, a novel CD6 ligand, is associated with the aggressiveness and metastatic potential of human cancers, we te
Externí odkaz:
https://doaj.org/article/f287e4446e9b405d899bf9971cadfab5
Autor:
Alexander Stinson, Veronica J. Berrocal, Erica Bush, Catherine Spino, Dinesh Khanna, Mikel Gurrea-Rubio, Steven K. Lundy, Daniel E. Furst, Evan Wiewiora, David A. Fox, Ray A. Ohara, Shiv Pillai, Michael L. Whitfield, Phillip L. Campbell, Stephanie M. Rasmussen
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background Abnormalities in lymphocyte surface markers and functions have been described in systemic sclerosis (SSc), but conflicting results abound, and these studies often examined patients with heterogeneous disease duration, severity, clinical ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed51e0424d89d151dde86b6fd2fc2e34
https://doaj.org/article/8059ca6da5dc4ce5a4315c1da87cc713
https://doaj.org/article/8059ca6da5dc4ce5a4315c1da87cc713
Autor:
Henriette A. Remmer, Ray A. Ohara, Stephanie M. Rasmussen, Phillip L. Campbell, Thomas M. Lanigan, Jeffrey H. Ruth, Takeo Isozaki, David A. Fox, Kevin C. Chung, Gautam Edhayan, Andrew G. Urquhart, Jeffrey N. Lawton
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Objective To explore the intrinsic role of inhibitor of DNA binding 1 (ID‐1) in rheumatoid arthritis (RA) fibroblast‐like synoviocytes (FLS) and to investigate whether ID‐1 is citrullinated and autoantigenic in RA. Methods RA patient serum ID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d130ed335625b7fb39b543e6bda12635
https://doi.org/10.1002/art.40886
https://doi.org/10.1002/art.40886
Autor:
M. Asif Amin, Thomas M. Lanigan, Venkateshwar G. Keshamouni, Daniel P. Weber, Feng Lin, Pei-Suen Tsou, Phillip L. Campbell, Jeffrey H. Ruth, Qi Wu, Nora G. Singer, Yang Mao-Draayer, David A. Fox, Stephanie M. Rasmussen, Peggy M. Randon, Kalana S. Athukorala, Matthew E. Lind, Mikel Gurrea-Rubio, Rosemary J. Gedert
Publikováno v:
JCI Insight
JCI Insight, Vol 6, Iss 5 (2021)
JCI Insight, Vol 6, Iss 5 (2021)
Limitations of checkpoint inhibitor cancer immunotherapy include induction of autoimmune syndromes and resistance of many cancers. Since CD318, a novel CD6 ligand, is associated with the aggressiveness and metastatic potential of human cancers, we te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4d7afc8cf6348520f41ee1d6e31b09b
http://europepmc.org/articles/PMC8021120
http://europepmc.org/articles/PMC8021120
Autor:
Thomas M, Lanigan, Stephanie M, Rasmussen, Daniel P, Weber, Kalana S, Athukorala, Phillip L, Campbell, David A, Fox, Jeffrey H, Ruth
Publikováno v:
Journal of Biological Methods
Cancer immunotherapy is a rapidly advancing and viable approach to treating cancer along with more traditional forms of therapy. Real-time cell analysis technologies that examine the dynamic interactions between cancer cells and the cells of the immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f3cf9279cff15f0bd1663135643d348
https://pubmed.ncbi.nlm.nih.gov/32577423
https://pubmed.ncbi.nlm.nih.gov/32577423
Autor:
Daniel E. Furst, Phillip L. Campbell, Shiv Pillai, Dinesh Khanna, Evan Wiewiora, David A. Fox, Michael L. Whitfield, Mikel Gurrea-Rubio, Ray A. Ohara, Alexander Stinson, Steven K. Lundy, Stephanie M. Rasmussen, Erica Bush, Veronica J. Berrocal, Catherine Spino
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-1 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ada5e3d3c0cfb83eb0a78fc759d19d8
https://doaj.org/article/30c30838e11149cd8e9dfd4d55aee135
https://doaj.org/article/30c30838e11149cd8e9dfd4d55aee135
Autor:
David A. Fox, Jeffrey H. Ruth, Thomas M. Lanigan, Stephanie M. Rasmussen, Kalana S. Athukorala, Phillip L. Campbell, Daniel P. Weber
Publikováno v:
Journal of Biological Methods. 7:e133
Cancer immunotherapy is a rapidly advancing and viable approach to treating cancer along with more traditional forms of therapy. Real-time cell analysis technologies that examine the dynamic interactions between cancer cells and the cells of the immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f58ac8bc4ce0e0cebf8cbafe8fa0c68
https://doi.org/10.14440/jbm.2020.323
https://doi.org/10.14440/jbm.2020.323
Autor:
Ray A. Ohara, Huadong Cui, Gospel Enyindah-Asonye, Nora G. Singer, Benlian Wang, Stephanie M. Rasmussen, Andries Zijlstra, Mark M. Moasser, Jeffrey H. Ruth, David A. Fox, Katie E. Hebron, Feng Lin, Yan Li, Danislav S. Spassov
It has been proposed that CD6, an important regulator of T cells, functions by interacting with its currently identified ligand, CD166, but studies performed during the treatment of autoimmune conditions suggest that the CD6–CD166 interaction might
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a08f1c1c1757c9c37632f430f5efb3d
https://europepmc.org/articles/PMC5565428/
https://europepmc.org/articles/PMC5565428/
